MR
Marpai, Inc.
MRAI · OTC
$3.32 +7.44% (+$0.23)
1M +51.52%
Market Cap $77.9M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$2.85
14.2% downside
Current Price
$3.32
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MRAI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
38 /100
Fair P/S 4.68x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 9.41%
Book val. growth N/A
EPS growth N/A
Profitability
9 /100
Weak Op. margin 81.73%
Gross margin 25.50%
FCF margin 52.33%
Quality
79 /100
Excellent Asset turnover 1.76x
ROIC 98.51%
ROA 178.37%
Debt
0 /100
High Int. coverage -3.75x
Current ratio 0.38x
Debt/Assets N/A
Stability
28 /100
Unstable EPS volatility 18.10%
Beta 4.71x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MRAI
Online
Sector
Healthcare
Industry
Medical - Healthcare Plans
CEO
Damien Francis Lamendola
Employees
107
Headquarters
Tampa
Upcoming events
11 NOV
Earnings
Upcoming earnings report